| Efficacy and biological activity of imatinib in metastatic dermatofibrosarcoma protuberans (DFSP) S Stacchiotti, MA Pantaleo, T Negri, A Astolfi, M Tazzari, GP Dagrada, ... Clinical Cancer Research 22 (4), 837-846, 2016 | 92 | 2016 |
| Activity of sunitinib in extraskeletal myxoid chondrosarcoma S Stacchiotti, MA Pantaleo, A Astolfi, GP Dagrada, T Negri, AP Dei Tos, ... European Journal of Cancer 50 (9), 1657-1664, 2014 | 85 | 2014 |
| Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma A Lladser, K Ljungberg, H Tufvesson, M Tazzari, AK Roos, AFG Quest, ... Cancer immunology, immunotherapy 59, 81-92, 2010 | 68 | 2010 |
| The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture S Di Blasio, GF van Wigcheren, A Becker, A van Duffelen, M Gorris, ... Nature Communications 11 (1), 2749, 2020 | 65 | 2020 |
| Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the … C Camisaschi, P Filipazzi, M Tazzari, C Casati, V Beretta, L Pilla, ... Cancer Immunology, Immunotherapy 62, 897-908, 2013 | 49 | 2013 |
| Adaptive immunity in fibrosarcomatous dermatofibrosarcoma protuberans and response to imatinib treatment M Tazzari, V Indio, B Vergani, L De Cecco, F Rini, T Negri, C Camisaschi, ... Journal of Investigative Dermatology 137 (2), 484-493, 2017 | 35 | 2017 |
| Targeting immune regulatory networks to counteract immune suppression in cancer C Camisaschi, V Vallacchi, E Vergani, M Tazzari, S Ferro, A Tuccitto, ... Vaccines 4 (4), 38, 2016 | 32 | 2016 |
| Dendritic cell vaccination in metastatic melanoma turns “non-T cell inflamed” into “T-cell inflamed” tumors J Bulgarelli, M Tazzari, AM Granato, L Ridolfi, S Maiocchi, F De Rosa, ... Frontiers in immunology 10, 2353, 2019 | 29 | 2019 |
| Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial–Mesenchymal Transition–like Process and 22q Loss S Stacchiotti, A Astolfi, A Gronchi, A Fontana, MA Pantaleo, T Negri, ... Molecular Cancer Research 14 (9), 820-829, 2016 | 29 | 2016 |
| Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti … M Tazzari, T Negri, F Rini, B Vergani, V Huber, A Villa, P Dagrada, ... British journal of cancer 111 (7), 1350-1362, 2014 | 27 | 2014 |
| Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report M Tazzari, E Palassini, B Vergani, A Villa, F Rini, T Negri, C Colombo, ... BMC cancer 15, 1-8, 2015 | 24 | 2015 |
| Immunomodulatory factors control the fate of melanoma tumor initiating cells A Tuccitto, M Tazzari, V Beretta, F Rini, C Miranda, A Greco, M Santinami, ... Stem Cells 34 (10), 2449-2460, 2016 | 23 | 2016 |
| Complex immune contextures characterise malignant peritoneal mesothelioma: loss of adaptive immunological signature in the more aggressive histological types M Tazzari, S Brich, A Tuccitto, F Bozzi, V Beretta, RD Spagnuolo, T Negri, ... Journal of Immunology Research 2018, 2018 | 22 | 2018 |
| Modulation of the myeloid compartment of the immune system by angiogenic-and kinase inhibitor-targeted anti-cancer therapies C Castelli, L Rivoltini, M Rodolfo, M Tazzari, C Belgiovine, P Allavena Cancer Immunology, Immunotherapy 64, 83-89, 2015 | 18 | 2015 |
| Molecular determinants of soft tissue sarcoma immunity: targets for immune intervention M Tazzari, L Bergamaschi, A De Vita, P Collini, M Barisella, A Bertolotti, ... International Journal of Molecular Sciences 22 (14), 7518, 2021 | 17 | 2021 |
| Sunitinib-induced morpho-functional changes and drug effectiveness in malignant solitary fibrous tumours RD Spagnuolo, S Brich, F Bozzi, E Conca, C Castelli, M Tazzari, ... Oncotarget 7 (29), 45015, 2016 | 16 | 2016 |
| Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients V Huber, L Di Guardo, L Lalli, D Giardiello, A Cova, P Squarcina, P Frati, ... Journal for ImmunoTherapy of Cancer 9 (2), 2021 | 13 | 2021 |
| Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma C Castelli, M Tazzari, T Negri, B Vergani, L Rivoltini, S Stacchiotti, S Pilotti Journal of translational medicine 11, 1-4, 2013 | 9 | 2013 |
| Immunotherapy in soft tissue sarcoma: current evidence and future perspectives in a variegated family of different tumor GG Baldi, A Gronchi, M Tazzari, S Stacchiotti Expert Review of Anticancer Therapy 22 (5), 491-503, 2022 | 8 | 2022 |
| Effects of a diet based on foods from symbiotic agriculture on the gut microbiota of subjects at risk for metabolic syndrome S Turroni, E Petracci, V Edefonti, AM Giudetti, F D’Amico, L Paganelli, ... Nutrients 13 (6), 2081, 2021 | 7 | 2021 |
